Home » Tenders » Americas » Brazil » Registration of Prices for the Eventual Acquisition of Oncology and Adjuvant... Tender

Registration of Prices for the Eventual Acquisition of Oncology and Adjuvant Medications... Tender

Download Documents

RONDONIA STATE GOVERNMENT has floated a tender for Registration of Prices for the Eventual Acquisition of Oncology and Adjuvant Medications (Sunitinib, Nivolumab, Pembrolizumab, Etc.).. The project location is Brazil and the tender is closing on 08 Apr 2024. The tender notice number is 728/2023, while the TOT Ref Number is 98676917. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Brazil

Summary : Registration of Prices for the Eventual Acquisition of Oncology and Adjuvant Medications (Sunitinib, Nivolumab, Pembrolizumab, Etc.).

Deadline : 08 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98676917

Document Ref. No. : 728/2023

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : RONDONIA STATE GOVERNMENT
Av. Farquar, 2986 - Pedrinhas - Edificio Rio Pacaas Novos, 2 And - Pedrinhas - Porto Velho (RO)
Telephone: (0xx69) 32129243
Fax: (0xx69)
Brazil

Tender Details

Object: Electronic Auction - Price registration for the possible acquisition of oncological and adjuvant medications (sunitinib, nivolumab, pembrolizumab, etc.). 59 hours and from 2:00 pm to 5:59 pm

Proposal Delivery: from 12/019981d172c851bd4e8a1788d5726c2d33/2024 at 08:00

SUNITINIB, MALATE COMPOSITION, CONCENTRATION 50 MG

Quantity: 4416

IMATINIB MESYLATE, DOSAGE 100 MG

Quantity: 720

OSIMERTINIB, CONCENTRATION 80 MG

Quantity: 1440

NINTEDANIB, SALT ESYLATE COMPOSITION, CONCENTRATION 150 MG

Quantity: 28800

NIVOLUMAB, CONCENTRATION 10 MG/ML, 19981d172c851bd4e8a1788d5726c2d3PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 936

NIVOLUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 1512

OCRELIZUMAB, CONCENTRATION 30 MG/ML, PHARMACEUTICAL FORM SOLUTION FOR INFUSION

Quantity: 48

OLAPAR IBE, CONCENTRATION 150 MG

Quantity: 2880

PALBOCICLIBE, CO19981d172c851bd4e8a1788d5726c2d3NCENTRATION 125 MG

Quantity: 2016

PAZOPANIB, CONCENTRATION 400 MG

Quantity: 4320

PANITUMOMAB, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 1440

PEMBROLIZUMAB, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM EUTICA INJECTABLE SOLUTION

Quantity: 648

PERTUZUMAB, CONCENTRATION 3019981d172c851bd4e8a1788d5726c2d3MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 120

PIRFENIDONE, CONCENTRATION 267 MG

Quantity: 25920

RIBOCICLIB, SUCCINATE COMPOSITION, CONCENTRATION 200 MG

Quantity: 966

RITUXIMAB, DOSAGE 10MG/ML, INDICATION INJECTABLE SOLUTION EL

Quantity: 472

RITUXIMAB, DOSAGE 10MG/ML, INDICATIONS ONLY19981d172c851bd4e8a1788d5726c2d3INJECTABLE SOLUTION

Quantity: 1248

RUXOLITINIB, CONCENTRATION 5 MG

Quantity: 1440

RUXOLITINIB, CONCENTRATION 20 MG

Quantity: 1440

SECUKINUMAB, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION

Quantity: 168

SO RAFENIB TOSYLATE, CONCENTRATION 200 MG

Quantity: 11520

TEMOZOLOMIDE19981d172c851bd4e8a1788d5726c2d3, CONCENTRATION 2...